434 related articles for article (PubMed ID: 30991286)
1. Yinchenhao decoction suppresses rat liver fibrosis involved in an apoptosis regulation mechanism based on network pharmacology and transcriptomic analysis.
Cai FF; Bian YQ; Wu R; Sun Y; Chen XL; Yang MD; Zhang QR; Hu Y; Sun MY; Su SB
Biomed Pharmacother; 2019 Jun; 114():108863. PubMed ID: 30991286
[TBL] [Abstract][Full Text] [Related]
2. [Effects of Chinese herbal medicine Yinchenhao Decoction on expressions of apoptosis-related genes in dimethylnitrosamine- or carbon tetrachloride-induced liver cirrhosis in rats].
Sun MY; Wang L; Mu YP; Liu C; Bian YQ; Wang XN; Liu P
Zhong Xi Yi Jie He Xue Bao; 2011 Apr; 9(4):423-34. PubMed ID: 21486556
[TBL] [Abstract][Full Text] [Related]
3. Yinchenhao decoction attenuates obstructive jaundice-induced liver injury and hepatocyte apoptosis by suppressing protein kinase RNA-like endoplasmic reticulum kinase-induced pathway.
Wu YL; Li ZL; Zhang XB; Liu H
World J Gastroenterol; 2019 Nov; 25(41):6205-6221. PubMed ID: 31749592
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of Yinchenhao decoction in treating obstructive-jaundice-induced liver injury based on Nrf2 signaling pathway.
Liu JJ; Xu Y; Chen S; Hao CF; Liang J; Li ZL
World J Gastroenterol; 2022 Aug; 28(32):4635-4648. PubMed ID: 36157920
[TBL] [Abstract][Full Text] [Related]
5. Yinchenhao Decoction Alleviates Liver Fibrosis by Regulating Bile Acid Metabolism and TGF-β/Smad/ERK Signalling Pathway.
Cai FF; Wu R; Song YN; Xiong AZ; Chen XL; Yang MD; Yang L; Hu Y; Sun MY; Su SB
Sci Rep; 2018 Oct; 8(1):15367. PubMed ID: 30337590
[TBL] [Abstract][Full Text] [Related]
6. Network pharmacology based research into the effect and mechanism of Yinchenhao Decoction against Cholangiocarcinoma.
Chen Z; Lin T; Liao X; Li Z; Lin R; Qi X; Chen G; Sun L; Lin L
Chin Med; 2021 Jan; 16(1):13. PubMed ID: 33478536
[TBL] [Abstract][Full Text] [Related]
7. Mechanism for hepato-protective action of Liangxue Huayu Recipe (LHR): blockade of mitochondrial cytochrome c release and caspase activation.
Jiang ZQ; Yan XJ; Bi L; Chen JP; Zhou Q; Chen WP
J Ethnopharmacol; 2013 Jul; 148(3):851-60. PubMed ID: 23711831
[TBL] [Abstract][Full Text] [Related]
8. Xiaoyaosan decoction alleviated rat liver fibrosis via the TGFβ/Smad and Akt/FoxO3 signaling pathways based on network pharmacology analysis.
Zhou Y; Wu R; Cai FF; Zhou WJ; Lu YY; Zhang H; Chen QL; Su SB
J Ethnopharmacol; 2021 Jan; 264():113021. PubMed ID: 32479885
[TBL] [Abstract][Full Text] [Related]
9. A bioinformatics investigation into the pharmacological mechanisms of the effect of the Yinchenhao decoction on hepatitis C based on network pharmacology.
Zhang J; Liu X; Wu J; Zhou W; Tian J; Guo S; Jia SS; Meng Z; Ni M
BMC Complement Med Ther; 2020 Feb; 20(1):50. PubMed ID: 32050950
[TBL] [Abstract][Full Text] [Related]
10. Optimized therapeutic potential of Yinchenhao decoction for cholestatic hepatitis by combined network meta-analysis and network pharmacology.
Luo S; Huang M; Lu X; Zhang M; Xiong H; Tan X; Deng X; Zhang W; Ma X; Zeng J; Efferth T
Phytomedicine; 2024 Jul; 129():155573. PubMed ID: 38583348
[TBL] [Abstract][Full Text] [Related]
11. [Formula-syndrome correlation study of three classical anti-jaundice formulas in inhibition of liver fibrosis induced by dimethylnitrosamine in rats].
Bian YQ; Ning BB; Cao HY; Lu Y; Liu C; Chen GF; Liu J; Liu P; Sun MY
Zhong Xi Yi Jie He Xue Bao; 2012 Dec; 10(12):1405-12. PubMed ID: 23257134
[TBL] [Abstract][Full Text] [Related]
12. Active Compounds Derived from Fuzheng Huayu Formula Protect Hepatic Parenchymal Cells from Apoptosis Based on Network Pharmacology and Transcriptomic Analysis.
Wu R; Dong S; Cai FF; Chen XL; Yang MD; Liu P; Su SB
Molecules; 2019 Jan; 24(2):. PubMed ID: 30669350
[TBL] [Abstract][Full Text] [Related]
13. [Recipe-syndrome correlation and pathogenesis mechanism of Yinchenhao Decoction in intervening dimethylnitrosamine induced liver cirrhosis progress in rats].
Liu C; Liu P; Tao Q
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Aug; 30(8):845-50. PubMed ID: 21038655
[TBL] [Abstract][Full Text] [Related]
14. Identification of the active compounds and significant pathways of yinchenhao decoction based on network pharmacology.
Huang J; Cheung F; Tan HY; Hong M; Wang N; Yang J; Feng Y; Zheng Q
Mol Med Rep; 2017 Oct; 16(4):4583-4592. PubMed ID: 28791364
[TBL] [Abstract][Full Text] [Related]
15. Yangyinghuoxue decoction exerts a treatment effect on hepatic fibrosis by PI3K/AKT pathway in rat model: based on the network pharmacology and molecular docking.
Bai YM; Liang S; Zhou B
Aging (Albany NY); 2024 Feb; 16(4):3773-3789. PubMed ID: 38364259
[TBL] [Abstract][Full Text] [Related]
16. Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula.
Li H
J Ethnopharmacol; 2020 Apr; 251():112442. PubMed ID: 31891799
[TBL] [Abstract][Full Text] [Related]
17. Sini San ameliorates CCl4-induced liver fibrosis in mice by inhibiting AKT-mediated hepatocyte apoptosis.
Jiang M; Huang C; Wu Q; Su Y; Wang X; Xuan Z; Wang Y; Xu F; Ge C
J Ethnopharmacol; 2023 Mar; 303():115965. PubMed ID: 36460296
[TBL] [Abstract][Full Text] [Related]
18. Chinese medicine CGA formula ameliorates liver fibrosis induced by carbon tetrachloride involving inhibition of hepatic apoptosis in rats.
Tian H; Liu L; Li Z; Liu W; Sun Z; Xu Y; Wang S; Liang C; Hai Y; Feng Q; Zhao Y; Hu Y; Peng J
J Ethnopharmacol; 2019 Mar; 232():227-235. PubMed ID: 30471378
[TBL] [Abstract][Full Text] [Related]
19. A network pharmacology approach to investigating the mechanism of Tanshinone IIA for the treatment of liver fibrosis.
Shi MJ; Yan XL; Dong BS; Yang WN; Su SB; Zhang H
J Ethnopharmacol; 2020 May; 253():112689. PubMed ID: 32101775
[TBL] [Abstract][Full Text] [Related]
20. Development of a novel anti-liver fibrosis formula with luteolin, licochalcone A, aloe-emodin and acacetin by network pharmacology and transcriptomics analysis.
Zhou Y; Wu R; Cai FF; Zhou WJ; Lu YY; Zhang H; Chen QL; Sun MY; Su SB
Pharm Biol; 2021 Dec; 59(1):1594-1606. PubMed ID: 34808067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
